| SC 13G/A | 2024-02-14 | GREENLIGHT CAPITAL INC | NeuBase Therapeutics, Inc. | 63,579 | 1.7% | EDGAR |
| SC 13D/A | 2023-09-20 | Symetryx Corp | NeuBase Therapeutics, Inc. | 0 | 0.0% | EDGAR |
| SC 13D/A | 2023-09-14 | Symetryx Corp | NeuBase Therapeutics, Inc. | 472,926 | 9.1% | EDGAR |
| SC 13D | 2023-08-31 | Symetryx Corp | NeuBase Therapeutics, Inc. | 428,444 | 13.8% | EDGAR |
| SC 13G/A | 2023-01-27 | Kershner Trading Americas,LLC | NeuBase Therapeutics, Inc. | 1,497,226 | 4.5% | EDGAR |
| SC 13G/A | 2022-02-14 | GREENLIGHT CAPITAL INC | NeuBase Therapeutics, Inc. | 1,271,596 | 3.9% | EDGAR |
| SC 13G/A | 2021-02-16 | GREENLIGHT CAPITAL INC | NeuBase Therapeutics, Inc. | 945,196 | 4.1% | EDGAR |
| SC 13G/A | 2020-12-29 | Kershner Trading Americas,LLC | NeuBase Therapeutics, Inc. | 1,339,000 | 5.8% | EDGAR |
| SC 13G/A | 2020-05-01 | HIRSCHMAN ORIN | NeuBase Therapeutics, Inc. | 563,972 | 2.4% | EDGAR |
| SC 13G | 2019-08-27 | Titcomb Shawn | NeuBase Therapeutics, Inc. | 861,394 | 5.0% | EDGAR |
| SC 13D | 2019-07-22 | Stephan Dietrich A | NeuBase Therapeutics, Inc. | 5,859,569 | 34.3% | EDGAR |
| SC 13G | 2019-07-22 | CARNEGIE MELLON UNIVERSITY | NeuBase Therapeutics, Inc. | 939,412 | 5.5% | EDGAR |
| SC 13G | 2019-07-22 | Thadke Shivaji | NeuBase Therapeutics, Inc. | 1,019,055 | 6.0% | EDGAR |
| SC 13G | 2019-07-18 | Kershner Trading Americas,LLC | NeuBase Therapeutics, Inc. | 467,600 | 16.5% | EDGAR |
| SC 13G | 2019-07-16 | GREENLIGHT CAPITAL INC | NeuBase Therapeutics, Inc. | 957,331 | 5.6% | EDGAR |
| SC 13G/A | 2018-02-15 | HIRSCHMAN ORIN | Ohr Pharmaceutical Inc | 2,855,135 | 5.1% | EDGAR |
| SC 13G/A | 2017-02-15 | HIRSCHMAN ORIN | Ohr Pharmaceutical Inc | 2,759,939 | 7.7% | EDGAR |
| SC 13D/A | 2016-08-02 | Slakter Jason Scott | Ohr Pharmaceutical Inc | 1,195,724 | 3.7% | EDGAR |
| SC 13G/A | 2016-02-16 | Broadfin Capital, LLC | Ohr Pharmaceutical Inc | 0 | 0.0% | EDGAR |
| SC 13G/A | 2016-02-12 | HIRSCHMAN ORIN | Ohr Pharmaceutical Inc | 2,740,939 | 9.0% | EDGAR |